United States of America based
Developer of novel therapeutics designed to treat cancer. The Company's proprietary platform focuses on the tumor microenvironment and data science to identify novel tumor-selective targets and anti-tumor antibodies with unprecedented speed.
TechnologiesAI Companies (Drug Discovery)
Assess and prioritize a library of drug candidates derived from analyzing tumor microenvironments. Allows researchers to: Simultaneously discover novel targets and functional antibodies for cancer.
No pipelines published yet
No services posted yet